High IL-18 (interferon-γ inducing factor) concentration in a purine nucleoside phosphorylase deficient patient

被引：8
|
作者：
Yamamoto, T
Moriwaki, Y
Matsui, K
Takahashi, S
Tsutsui, H
Yoshimoto, T
Okamura, H
Nakanishi, K
Kurosawa, Y
Yamaguchi, S
Sasaki, Y
Higashino, K
机构：
[1] Hyogo Coll Med, Dept Internal Med 3, Nishinomiya, Hyogo 6638501, Japan
[2] Hyogo Coll Med, Dept Immunol & Med Zool, Nishinomiya, Hyogo 6638501, Japan
[3] Hyogo Coll Med, Inst Adv Med Sci, Host Def Lab, Nishinomiya, Hyogo 6638501, Japan
[4] Keio Univ, Sch Med, Dept Pediat, Tokyo, Japan
[5] Kitasato Inst Hosp, Dept Pediat, Tokyo, Japan
[6] Natl Inst Infect Dis, Dept Safety Res Biol, Tokyo, Japan
来源：
ARCHIVES OF DISEASE IN CHILDHOOD | 1999年 / 81卷 / 02期
关键词：
purine nucleoside phosphorylase deficiency; interferon-gamma inducing factor; cytokines;
D O I：
10.1136/adc.81.2.179
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
The plasma concentration of IL-18 (interferon-gamma inducing factor) was severely increased in a 3 year old boy with purine nucleoside phosphorylase (PNP) deficiency. The presence and activity of IL-18 were confirmed by immunoblotting and bioassay, respectively. These results suggest that IL-18 may be abundantly produced and secreted into plasma by PNP deficient macrophages in PNP deficiency.
引用
收藏
页码：179 / 180
页数：2
相关论文
共 50 条
  • [41] Immunohistochemical and immuno-electron-microscopic detection of interferon-γ-inducing factor (”interleukin-18”) in mouse intestinal epithelial cells
    Makoto Takeuchi
    Yasushi Nishizaki
    Osamu Sano
    Tsunetaka Ohta
    Masao Ikeda
    Masashi Kurimoto
    Cell and Tissue Research, 1997, 289 : 499 - 503
  • [42] In vivo antitumor effects of murine interferon- γ -inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites
    M. J. Micallef
    Kenshi Yoshida
    Sachiko Kawai
    Toshiharu Hanaya
    Keizo Kohno
    Shigeyuki Arai
    Tadao Tanimoto
    Kakuji Torigoe
    Mitsukiyo Fujii
    Masao Ikeda
    Masashi Kurimoto
    Cancer Immunology, Immunotherapy, 1997, 43 : 361 - 367
  • [43] Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes
    F. Nicoletti
    I. Conget
    R. Di Marco
    A. M. Speciale
    R. Morìnigo
    K. Bendtzen
    R. Gomis
    Diabetologia, 2001, 44 : 309 - 311
  • [44] Serum levels of the interferon-γ-inducing cytokine interleukin-18 are increased in individuals at high risk of developing Type I diabetes
    Nicoletti, F
    Conget, I
    Di Marco, R
    Speciale, AM
    Morìngo, R
    Bendtzen, K
    Gomis, R
    DIABETOLOGIA, 2001, 44 (03) : 309 - 311
  • [45] A simple and sensitive bioassay for the detection of human interleukin-18/interferon-γ-inducing factor using human myelomonocytic KG-1 cells
    Konishi, K
    Tanabe, F
    Taniguchi, M
    Yamauchi, H
    Tanimoto, T
    Ikeda, M
    Orita, K
    Kurimoto, M
    JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 209 (02) : 187 - 191
  • [46] Nitric oxide prevents IL-1β and IFN-γ-inducing factor (IL-18) release from macrophages by inhibiting caspase-1 (IL-1β-converting enzyme)
    Kim, YM
    Talanian, RV
    Li, JR
    Billiar, TR
    JOURNAL OF IMMUNOLOGY, 1998, 161 (08): : 4122 - 4128
  • [47] Gamma interferon (IFN-γ) and IFN-γ-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo
    Sasaki, H
    Balto, K
    Kawashima, N
    Eastcott, J
    Hoshino, K
    Akira, S
    Stashenko, P
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 2004, 11 (01) : 106 - 110
  • [48] Platelet activating factor receptor-deficient mice present delayed interferon-γ upregulation and high susceptibility to Leishmania amazonensis infection
    Santiago, Helton C.
    Braga Pires, Maira Faria
    Souza, Daniele G.
    Roffe, Ester
    Cortes, Denise F.
    Tafuri, Wagner L.
    Teixeira, Mauro M.
    Vieira, Leda Q.
    MICROBES AND INFECTION, 2006, 8 (11) : 2569 - 2577
  • [49] Leptin-deficient (ob/ob) mice are protected from T cell-mediated hepatotoxicity:: Role of tumor necrosis factor α and IL-18
    Faggioni, R
    Jones-Carson, J
    Reed, DA
    Dinarello, CA
    Feingold, KR
    Grunfeld, C
    Fantuzzi, G
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (05) : 2367 - 2372
  • [50] Expression of interferon gamma inducing factor (IGIF or IL18) in EBV-associated lymphoproliferative diseases with vascular damage and necrosis.
    Feldstein, JT
    Jaffe, ES
    Berkowitz, JR
    Burd, PR
    Kingma, DW
    Ferry, JA
    Harris, NL
    Wilson, WH
    Tosato, G
    BLOOD, 1997, 90 (10) : 333 - 333
12345